Rahsaan Thompson
Director/Board Member chez Oakland Museum of California
Profil
Rahsaan W.
Thompson is currently the Director at Oakland Museum of California.
Previously, he worked as Corporate Counsel at McKesson Corp., General Counsel at Opiant Pharmaceuticals, Inc., Associate General Counsel at Abraxis BioScience, Inc., Vice President-Law at Actelion Pharmaceuticals US, Inc., and Executive Vice President & General Counsel at Gritstone bio, Inc. He also served as the Chief Legal Officer at Lyell Immunopharma, Inc. from 2022 to 2023.
Thompson received his undergraduate degree from Southern Methodist University and his graduate degree from Hofstra University.
Postes actifs de Rahsaan Thompson
| Sociétés | Poste | Début |
|---|---|---|
| Oakland Museum of California | Director/Board Member | - |
Anciens postes connus de Rahsaan Thompson
| Sociétés | Poste | Fin |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | General Counsel | 16/06/2023 |
| MCKESSON CORPORATION | General Counsel | - |
Abraxis BioScience, Inc.
 Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | General Counsel | - |
Actelion Pharmaceuticals US, Inc.
 Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | General Counsel | - |
| GRITSTONE BIO, INC. | General Counsel | - |
Formation de Rahsaan Thompson
| Southern Methodist University | Undergraduate Degree |
| Hofstra University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| MCKESSON CORPORATION | Distribution Services |
| GRITSTONE BIO, INC. | Health Technology |
| LYELL IMMUNOPHARMA, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Opiant Pharmaceuticals, Inc.
 Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
Abraxis BioScience, Inc.
Abraxis BioScience, Inc. Pharmaceuticals: MajorHealth Technology Abraxis Bioscience, Inc. develops therapeutics for cancer, infectious diseases and other critical illnesses. Its development platform uses nanoparticle albumin-bound technology to deliver drugs to tumors that produce SPARC. Abraxene, the first protein-based nanoparticle chemotherapeutic compound, is FDA approved for treating metastatic breast cancer. Abraxis Bioscience is focused on expanding the use of Abraxene and developing other drug candidates utilizing the same technology. Abraxene is approved for marketing in over 35 countris and the company has manufacturing facilities in the United States and Switzerland. Abraxis Bioscience was organized in 2007 from the oncology and research businesses of American Pharmaceutical Partners, Inc. and is headquartered in Los Angeles, CA. | Health Technology |
| Oakland Museum of California | |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
